Vemurafenib Not Yet Recruiting Phase 2 Trials for BRAF V600E Mutation Present / Papillary Craniopharyngioma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs